Authors
Ani Nalbandian, Kartik Sehgal, Aakriti Gupta, Mahesh V Madhavan, Claire McGroder, Jacob S Stevens, Joshua R Cook, Anna S Nordvig, Daniel Shalev, Tejasav S Sehrawat, Neha Ahluwalia, Behnood Bikdeli, Donald Dietz, Caroline Der-Nigoghossian, Nadia Liyanage-Don, Gregg F Rosner, Elana J Bernstein, Sumit Mohan, Akinpelumi A Beckley, David S Seres, Toni K Choueiri, Nir Uriel, John C Ausiello, Domenico Accili, Daniel E Freedberg, Matthew Baldwin, Allan Schwartz, Daniel Brodie, Christine Kim Garcia, Mitchell SV Elkind, Jean M Connors, John P Bilezikian, Donald W Landry, Elaine Y Wan
Publication date
2021/4
Source
Nature medicine
Volume
27
Issue
4
Pages
601-615
Publisher
Nature Publishing Group
Description
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in global healthcare crises and strained health resources. As the population of patients recovering from COVID-19 grows, it is paramount to establish an understanding of the healthcare issues surrounding them. COVID-19 is now recognized as a multi-organ disease with a broad spectrum of manifestations. Similarly to post-acute viral syndromes described in survivors of other virulent coronavirus epidemics, there are increasing reports of persistent and prolonged effects after acute COVID-19. Patient advocacy groups, many members of which identify themselves as long haulers, have helped contribute to the recognition of post-acute COVID-19, a syndrome characterized by persistent symptoms and/or delayed or long-term complications beyond 4 …
Total citations
Scholar articles
A Nalbandian, K Sehgal, A Gupta, MV Madhavan… - Nature medicine, 2021